Can better staff talk save kids with cancer? new study tests team training
NCT ID NCT07083674
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program to improve how hospital staff communicate when caring for children with cancer in low-resource settings. The program includes training and new protocols for teamwork. Researchers will measure changes in communication quality over six months. Only 8 hospitals will take part, so results are early and limited.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- communication training program
- What this could lead to
- If successful, this could show that better teamwork and communication among hospital staff improves care for children with cancer in low-resource settings.
- What could go wrong
- This is a very small study (8 hospitals) testing a new program, so results may not apply widely. It focuses on staff behavior, not directly on patient survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 8 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2027
An estimate. Start dates often move.
- Expected to finish
-
Aug 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Hospitals identified as being in lowest quartile of communication quality, as defined by prior cross-sectional CritCom analysis and measured as the overall CritCom score. * All Global Alliance hospitals providing childhood cancer care will be eligible to participate. * Individual participants will be included if they care for hospitalized children with cancer at risk of deterioration. Exclusion Criteria: * None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pediatric cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Washington University in St. Louis
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can freezing ovarian tissue protect fertility in children facing cancer treatment?
- Tumor profiling may unlock targeted drug options for pediatric cancers
- Can a new pill tame childhood cancers that Won't quit?
- A bike ride could reveal hidden heart risks in young cancer survivors
- Can a new combo drug tame childhood leukemia that Won't quit?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?